azathioprine has been researched along with Congestive Ophthalmopathy in 6 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartalena, L | 1 |
| Tanda, ML | 1 |
| Taylor, P | 1 |
| Rajendram, R | 2 |
| Hanna, S | 1 |
| Wilson, V | 1 |
| Pell, J | 2 |
| Li, C | 2 |
| Cook, A | 2 |
| Gattamaneni, R | 2 |
| Plowman, N | 2 |
| Jackson, S | 2 |
| Hills, R | 2 |
| French, R | 1 |
| Uddin, JM | 2 |
| Lee, RWJ | 2 |
| Dayan, CM | 2 |
| Taylor, PN | 1 |
| Wilson, VJ | 1 |
| Harris, N | 1 |
| Morris, OC | 1 |
| Tomlinson, M | 1 |
| Yarrow, S | 1 |
| Garrott, H | 1 |
| Herbert, HM | 1 |
| Dick, AD | 1 |
| Jain, R | 1 |
| Olver, J | 1 |
| Hurel, SJ | 1 |
| Bremner, F | 1 |
| Drummond, SR | 1 |
| Kemp, E | 1 |
| Ritchie, DM | 1 |
| Rumsey, N | 1 |
| Morris, D | 1 |
| Lane, C | 1 |
| Palaniappan, N | 1 |
| Ezra, DG | 1 |
| Potts, MJ | 1 |
| Rose, GE | 1 |
| Bunce, C | 1 |
| Zhou, X | 1 |
| Zhou, D | 1 |
| Wang, J | 1 |
| Chen, G | 1 |
| Gonzales, M | 1 |
| Fratianni, C | 1 |
| Mamillapali, C | 1 |
| Khardori, R | 1 |
| Levy, SL | 1 |
| Salvi, SM | 1 |
3 reviews available for azathioprine and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Current concepts regarding Graves' orbitopathy.
Topics: Antithyroid Agents; Azathioprine; Biological Factors; Cyclosporine; Glucocorticoids; Graves Ophthalm | 2022 |
Treatment strategies for Graves' ophthalmopathy: a network meta-analysis.
Topics: Antibodies, Monoclonal, Humanized; Azathioprine; Combined Modality Therapy; Cyclosporine; Glucocorti | 2020 |
Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
Topics: Allergens; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Ant | 2012 |
2 trials available for azathioprine and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial.
Topics: Azathioprine; Follow-Up Studies; Graves Ophthalmopathy; Humans; Inflammation; Quality of Life; Treat | 2023 |
Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial.
Topics: Adult; Aged; Azathioprine; Chemoradiotherapy; Double-Blind Method; Female; Graves Ophthalmopathy; Hu | 2018 |
1 other study available for azathioprine and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Reactivation of Darier's disease following Azathioprine treatment for thyroid eye disease.
Topics: Azathioprine; Darier Disease; Female; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Middl | 2013 |